Omigapil maleate
Cat. No.:YN270340
CAS No. :200189-97-5
产品名称: | Omigapil maleate |
CAS No.: | 200189-97-5 |
Chemical Name: | N-methyl-N-2-propyn-1-yl-dibenz[b,f]oxepin-10-methanamine, (2Z)-2-butenedioate |
Synonyms: | CGP3466B maleate |
分子量: | 391.42 |
分子式: | C₂₃H₂₁NO₅ |
SMILES: | C#CCN(C)CC1=CC2=CC=CC=C2OC3=CC=CC=C13.O=C(O)/C=C\C(O)=O |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | Omigapil maleate 是一种具有口服活性的GAPDH亚硝基化抑制剂,可消除 Aβ1-42诱导的小鼠 tau 乙酰化,记忆障碍和运动功能障碍,Omigapil maleate 具有研究阿尔茨海默症的潜力。Omigapil maleate (CGP3446B maleate) 是一种有效的凋亡 (apoptosis) 抑制剂。Omigapil maleate 可用于研究先天性肌营养不良 (CMD)。 |
IC50和靶点: | |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Waldemeier, P.C., Boulton, A.A., Cools, A.R., et al.Neurorescuing effects of the GAPDH ligand CGP 34668J. Neural Transm. Suppl.60,197-214(2000)
Kragten, E., Lalande, I., Zimmermann, K., et al.Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(2)-deprenylJ. Biol. Chem.273(10),5821-5828(1998)
Miller, R., Bradley, W., Cudkowicz, M., et al.Phase II/III randomized trial of TCH346 in patients with ALSNeurology69(8),776-784(2007)
Olanow, C.W., Schapira, A.H., LeWitt, P.A., et al.TCH346 as a neuroprotective drug in Parkinson's disease: a double blind, randomised, controlled trialLancet. Neurol.5(12),1013-1020(2006)